对于RNA输送的电离性脂质的合理设计和组合化学
Yue Xu1, Alex Golubovic1, Shufen Xu1
1Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada. bw.li@utoronto.ca.
Journal of materials chemistry. B
|June 22, 2023
概括
脂质纳米颗粒 (LNP) 对于提供RNA疗法至关重要. 本综述侧重于电离性脂质,mRNA疫苗和siRNA药物的LNP配方中的关键成分,探索它们的结构和合成.
科学领域:
- 生物技术是生物技术.
- 药物输送系统 药物输送系统
- 核酸治疗药物 核酸治疗药物
背景情况:
- 脂质纳米颗粒 (LNP) 已经彻底改变了核酸输送,使siRNA药物和mRNA疫苗的批准成为可能.
- 随着COVID-19的爆发,基于LNP的mRNA疫苗 (Comirnaty,Spikevax) 在公共卫生中发挥的关键作用得到了强调.
- 目前FDA批准的LNP配方除了可离子化脂质外,具有共同的结构成分.
研究的目的:
- 审查 RNA 输送的电离性脂质的最新进展.
- 探索电离性脂质的化学结构,合成途径和结构-活性关系.
- 为了强调可离子化脂质在基于LNP的治疗疗效中的重要性.
主要方法:
- 科学出版物和专利的文献评论.
- 分析电离性脂质的化学结构和合成路径.
- 在RNA输送的背景下检查结构-活性关系.
主要成果:
- 电离性脂质是成功的RNA输送LNP配方中的差异化成分.
- 在设计具有改进性质的新型电离性脂质方面取得了重大进展.
- 了解结构-活性关系是优化基于LNP的RNA疗法的关键.
结论:
- 电离性脂质是基于LNP的RNA传递效率的关键决定因素.
- 对电离性脂质设计的持续研究对于推进RNA疗法至关重要.
- 本综述提供了近几十年来RNA输送中电离性脂质的全面概述.
相关概念视频
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
RNA Interference
26.1K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.1K


